Edition:
United Kingdom

Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

1.85USD
17 Aug 2018
Change (% chg)

$-0.20 (-9.76%)
Prev Close
$2.05
Open
$1.93
Day's High
$1.96
Day's Low
$1.85
Volume
12,291
Avg. Vol
3,582
52-wk High
$4.21
52-wk Low
$1.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.39 -0.075
Mar '18 0.23 -0.109
FY 2017 Dec '17 0.87 -0.104
Sep '17 0.30 -0.112
Jun '17 0.21 -0.500
Mar '17 0.57 -0.151
FY 2016 Dec '16 0.99 -0.112
Sep '16 1.14 0.104
Jun '16 0.58 -0.173
Mar '16 0.81 -0.061
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. 9.46 300.64 45.44
P/E Low - Last 5 Yrs. 9.46 92.08 24.26
Beta -0.19 0.93 0.89
Price to Sales (TTM) 13.52 114.98 5.75
Price to Book (MRQ) 8.54 15.51 5.47
Price to Tangible Book (MRQ) 8.54 14.52 7.04
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 4.64 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -64.15 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago -7.80 80.50 5.64
Sales - 5 Yr. Growth Rate -16.73 32.27 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -189.65 29.15 20.60
EPS (TTM) vs TTM 1 Yr. Ago 1.75 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate -59.84 40.43 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 5.16 5.53 3.03
LT Debt to Equity (MRQ) 0.00 35.26 12.51
Total Debt to Equity (MRQ) 0.00 37.08 16.85
Interest Coverage (TTM) -- -102.44 32.63

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.17 54.37
Gross Margin - 5 Yr. Avg. -- 50.57 52.17
EBITD Margin (TTM) -195.94 -- --
EBITD - 5 Yr. Avg -377.16 -603.21 10.65
Operating Margin (TTM) -197.09 -759.76 4.32
Operating Margin - 5 Yr. Avg. -320.58 -625.13 6.06
Pre-Tax Margin (TTM) -253.47 -733.60 5.18
Pre-Tax Margin - 5 Yr. Avg. -264.44 -628.46 6.49
Net Profit Margin (TTM) -253.47 -734.98 1.48
Net Profit Margin - 5 Yr. Avg. -264.44 -631.51 2.77
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 194,134 23,229,989 860,364,355
Net Income/Employee (TTM) -492,081 3,144,143 101,205,920
Receivable Turnover (TTM) 4.40 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.19 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -48.89 -0.16 11.13
Return on Assets - 5 Yr. Avg. -57.32 3.50 12.40
Return on Investment (TTM) -119.26 1.78 14.61
Return on Investment - 5 Yr. Avg. -262.99 2.55 16.13
Return on Equity (TTM) -119.07 3.28 16.33
Return on Equity - 5 Yr. Avg. -367.36 3.42 17.39
  1 Year 3 Year 5 Year
Sales % 29.92 -25.44 -16.73
EPS (TTM) % 86.48 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cleveland Biolabs Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 5.99%
# of Holders: 23
Total Shares Held: 676,863
3 Mo. Net Change: 24,304
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 5
# Reduced Positions: 4
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.